Tag: Biotechnologies

Biotechnology is the use of living systems and organisms to develop or make products, or “any technological application that uses biological systems, living organisms, or derivatives thereof, to make or modify products or processes for specific use”. Depending on the tools and applications, it often overlaps with the (related) fields of bioengineering, biomedical engineering, biomanufacturing, molecular engineering, etc.

Ceapro Receives Research License from Health Canada Controlled Substances and Cannabis Branch

Ceapro Inc., a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced it has received special autho...

Merck KGaA Invests in Biotech Development Center in Switzerland

merck kgaa
Merck KGaA, a leading science and technology company, announced an investment of € 250 million in a new facility in Corsier-sur-Vevey, Switzerland – the Biotech Development Center – dedicated to biote...

Announced the Launch of the Unified Website for Biotechnology Regulation

The U.S. Food and Drug Administration, the Department of Agriculture and the Environmental Protection Agency launched a Unified Website for Biotechnology Regulation. The website streamlines informatio...

The Russian Export Center acted as BIOTECHMED 2019 General Partner

Global cooperation, international relations development and export of medical services were part of the agenda of the IV annual International Forum BIOTECHMED (September 16-17, Gelendzhik, Russia), tu...

Biotechnology Development Council Established in Russia

biotech-research
The Council for Biotechnology Development was established in Russia under the government's supervision. The relevant decree was signed by Russian Prime Minister Dmitry Medvedev. The new governmenta...

Erytech Received $57m from SQZ Biotechnologies for New Immune Modulating Therapies Development

biotech
Erytech Pharma has inked a deal with SQZ Biotechnologies Inc. to develop new immune modulating therapies. Under the agreement, Erytech will licence the rights to use its ERYCAPS platform to SQZ, whic...

New Biotechnology Company Launched by GT Healthcare

GT Apeiron Therapeutics, a novel biotechnology company, was launched with the backing from GT Healthcare and associated investors. The company also entered into a drug discovery collaboration with ...

Novel and First-in-Cass Drug Design Technology

Cyclica, a leading biotechnology company that commercialized Ligand Express announced its novel, first-in-class drug design technology, Ligand Design on stage at the Collision Conference in Toronto. ...

GeoVax and Leidos to Develop Malaria Vaccine Candidates

GeoVax Labs, Inc., a biotechnology company developing human vaccines, announced today that it has expanded its collaboration activities with Leidos, Inc. to develop malaria vaccine candidates. The wor...

Anixa, Wistar Institute and Dmitry I. Gabrilovich Focus on MDSC

Anixa Biosciences, Inc., a biotechnology company focused on using the body's immune system to fight cancer, today announced it has extended its collaboration with The Wistar Institute and Dmitry I. Ga...

Abilita Bio and Amgen in Multi-Target Research Team

amgen
Abilita Bio, Inc. announced that it has entered into a multi-target research collaboration agreement with Amgen, a world leader in biotechnology. Under the terms of the agreement, Abilita Bio will lev...

WuXi and Amicus are into Exclusive Manufacturing Partnership

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development and manufacturing, and Amicus Therapeutics, a glob...

Grey Wolf to Fund Development of Therapy Increasing Tumour Visibility

Grey Wolf targets ERAP antigen presentation pathways with the aim of ‘illuminating’ non-responsive tumours for attack and destruction by the immune system. Grey Wolf Therapeutics, a drug discovery ...

Launch of Company Focusing on Preventing Cancer Metastasis

HiberCell, a biotechnology company developing therapeutics focused on preventing cancer relapse and metastasis, launched on February 8 with $60.75M in Series A funding led by ARCH Venture Partners. Hi...

Korean Company Announces Publication of Patent Application

IntoCell, Inc., a Korea-based biotechnology company dedicated to the development and commercialisation of novel antibody drug conjugate (ADC) platform technologies, today announced the publication of ...

B-MoGen and CytoSen to Develop NK Therapies

B-MoGen Biotechnologies, Inc. and CytoSen Therapeutics announced today a research collaboration to develop the next generation of gene-modified Natural Killer Cell (NK) therapies. B-MoGen will utilize...